greeksoup/ stock research

Arcutis Biotherapeutics, Inc. 13F holders

272 funds reported a position in Arcutis Biotherapeutics, Inc. in their 13F for the quarter ended 30 June 2026, together 131.4 million shares worth $3.45 billion. Against the quarter before, 36 opened a position, 95 added, 100 trimmed and 36 sold out; together they sold a net 1.3 million shares. The largest holders: Montanova Capital, LLC, BlackRock, Inc. and Frazier Life Sciences Management, L.P.

Funds holding272+2 on Q1 2026
Shares they held131.4Mworth $3.45 billion
Net sold on the quarter1.3M sharesabout $33.8 million at the funds' values
Funds buying to selling131 to 136opened or added, to cut or sold
Opened 36Added 95Held 39Trimmed 100Sold out 36
Opened: 36 fundsAdded: 95 fundsHeld: 39 fundsTrimmed: 100 fundsSold out: 36 funds

What each fund did in ARQT against its 13F for the quarter before; a change under 0.1% of a holding counts as held

Q3 2024: 188 funds, 129.9 million shares188Q3 2024Q4 2024: 208 funds, 128.9 million shares208Q4 2024Q1 2025: 241 funds, 125.7 million shares241Q1 2025Q2 2025: 230 funds, 127.4 million shares230Q2 2025Q3 2025: 239 funds, 125.9 million shares239Q3 2025Q4 2025: 283 funds, 129.3 million shares283Q4 2025Q1 2026: 270 funds, 132.8 million shares270Q1 2026Q2 2026: 272 funds, 131.4 million shares272Q2 2026

Funds reporting a position in ARQT in their 13F, each quarter; hover a bar for the shares they held

Filed so far for the quarter to 30 September 2026

2,671 funds have filed their 13F for the quarter so far; the rest are due by 16 November 2026. Of those, 48 reported a position in Arcutis Biotherapeutics, Inc.: 13 opened one, 12 added, 7 trimmed and 3 sold out, a net 171,180 shares sold.

The largest moves in the name among the funds that have filed, against each fund's previous 13F.

The well-known funds

Of the 44 funds followed here, 8 reported a position in Arcutis Biotherapeutics, Inc. in a 13F for the quarter ended 30 June 2026. The largest: Geode Capital Management, 3.0 million shares worth $78.2 million, 0.0% of its reported book. In the quarter, 4 funds added or opened a position and 3 trimmed or sold out; together they bought a net 1.4 million shares, about $37.8 million at the funds' own value per share on 30 June 2026. A change under 0.1% of a holding counts as held.

FundSharesValueOf its bookChange on the quarterStatusQuarter endedFiling
Geode Capital Management2,982,446$78.2 million0.0%-62,860trimmed30 June 202613F
Citadel Advisors1,160,014$30.4 million0.0%+1,144,408added30 June 202613F
Two Sigma Investments663,877$17.4 million0.0%+429,570added30 June 202613F
Millennium Management564,072$14.8 million0.0%+514,739added30 June 202613F
Norges Bank392,300$10.3 million0.0%held30 June 202613F
Point72 Asset Management362,449$9.5 million0.0%-228,428trimmed30 June 202613F
FMR LLC305,969$8.0 million0.0%+27,233added30 June 202613F
Renaissance Technologies58,399$1.5 million0.0%-382,600trimmed30 June 202613F
Value is what the fund reported.
Read moreChange is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.

The largest holders

FundSharesShare of allValueOf its bookChange in sharesFiling
Montanova Capital, LLC12,437,0009.46%$326.1 million6.85%+110,00013F
BlackRock, Inc.10,545,4668.02%$276.5 million0.00%+1,345,05513F
Frazier Life Sciences Management, L.P.9,874,5117.51%$258.9 million5.64%no change13F
Rubric Capital Management LP8,271,5776.29%$216.9 million1.99%no change13F
Polar Capital Holdings Plc6,606,9455.03%$173.2 million0.49%+940,00513F
State Street Corp.5,822,8404.43%$152.7 million0.01%-473,35713F
Vanguard Capital Management LLC4,988,7563.80%$130.8 million0.00%+117,22013F
Morgan Stanley4,451,0143.39%$116.7 million0.01%+232,08313F
Jennison Associates LLC4,219,0583.21%$110.6 million0.07%-761,71213F
D. E. Shaw & Co., Inc.3,949,6093.01%$103.6 million0.07%+1,453,38713F
UBS Group AG3,333,0152.54%$87.4 million0.01%+3,79113F
Bank of America Corp.2,987,4312.27%$78.3 million0.01%+766,14213F
Geode Capital Management, LLC2,982,4462.27%$78.2 million0.00%-62,86013F
Vanguard Portfolio Management LLC2,429,0051.85%$63.7 million0.00%+474,32013F
Orbimed Advisors LLC2,042,0001.55%$53.5 million1.02%new13F
Franklin Resources Inc.1,930,9821.47%$50.6 million0.01%-366,96113F
American Century Companies Inc.1,925,0311.46%$50.5 million0.02%+461,80313F
Goldman Sachs Group Inc.1,668,3671.27%$43.7 million0.01%+65,35413F
Jupiter Topco LLC1,410,4351.07%$37.0 million0.01%first 13F13F
Oberweis Asset Management Inc.1,372,9411.04%$36.0 million0.74%+7,00013F
Gilder Gagnon Howe & Co. LLC1,313,2111.00%$34.4 million0.35%-2,990,79913F
GW&K Investment Management, LLC1,288,0180.98%$33.8 million0.26%+299,63113F
Pivotal bioVenture Partners Investment Advisor LLC1,265,2830.96%$33.2 million10.78%-90,60913F
Bamco Inc.1,253,1200.95%$32.9 million0.05%+180,93113F
Citadel Advisors LLC1,160,0140.88%$30.4 million0.02%+1,144,40813F
Federated Hermes, Inc.1,124,6290.86%$29.5 million0.04%+47,36213F
Perpetual Ltd1,109,6570.84%$29.1 million0.42%+200,11113F
Aberdeen Group plc1,098,4110.84%$28.8 million0.04%+453,34513F
Jones Hill Capital LP1,089,7010.83%$28.6 million6.07%new13F
Northern Trust Corp.1,058,5750.81%$27.8 million0.00%+82,06313F
Charles Schwab Investment Management Inc.1,050,9340.80%$27.6 million0.00%+38,37913F
Ensign Peak Advisors, Inc974,5340.74%$25.6 million0.04%-269,85313F
Candriam S.C.A.949,8390.72%$24.9 million0.11%-136,81213F
Driehaus Capital Management LLC878,4260.67%$23.0 million0.13%-1,347,60313F
Nuveen, LLC834,2610.63%$21.9 million0.01%-67,87313F
Vanguard Fiduciary Trust Co.815,1380.62%$21.4 million0.01%+43,37413F
Manufacturers Life Insurance Company, the811,7520.62%$21.3 million0.02%+307,89613F
Two Sigma Investments, LP663,8770.51%$17.4 million0.01%+429,57013F
Fishman Jay A Ltd595,0050.45%$15.6 million1.24%+28,27513F
Millennium Management LLC564,0720.43%$14.8 million0.01%+514,73913F
BNP Paribas Financial Markets547,2780.42%$14.3 million0.01%-264,86813F
Squarepoint Ops LLC537,7470.41%$14.1 million0.03%-565,74313F
Capitolis Liquid Global Markets LLC500,0000.38%$13.1 million0.06%no change13F
Nearwater Capital Markets, Ltd486,7000.37%$12.8 million0.22%-120,60013F
Adage Capital Partners GP, L.l.c.466,0000.35%$12.2 million0.02%+100,00013F
Marshall Wace, LLP446,8660.34%$11.7 million0.01%-1,984,91213F
Privium Fund Management B.V.399,3670.30%$10.5 million1.92%+78,39513F
Norges Bank392,3000.30%$10.3 million0.00%13F
Deutsche Bank AG382,6820.29%$10.0 million0.00%-7,16513F
Patient Square Capital LP370,0000.28%$9.7 million1.50%-30,64513F
The 50 largest of the 272 funds that reported a position in ARQT in their 13F for the quarter ended 30 June 2026, by the value each reported.
Read moreShare of all is the fund's part of all the shares the funds reported. Change is shares against the fund's 13F for the quarter before. A 13F lists a manager's long positions in US-listed shares at the quarter's end. What is a 13F?

Options the funds reported on ARQT

FundOptionShares under the optionsValue of those sharesQuarter endedFiling
Citadel AdvisorsCalls94,600$2.5 million30 June 202613F
Citadel AdvisorsPuts14,000$367,08030 June 202613F
A 13F lists calls and puts by the shares they cover and what those shares were worth at the quarter's end, not what the options cost.
Read moreThey are not counted in the holdings above. A put gains when the stock falls, a call when it rises, and a fund may hold either to hedge.

Schedule 13D and 13G filed on the name, last twelve months

FiledScheduleWhoHoldingOf the classEvent dateRule or purposeFiling
5 October 202613G/ABlackRock, Inc. and 1 other17.8 million14.1%30 September 2026passive, institutional (13d-1(b))EDGAR
14 August 202613GPolar Capital Holdings Plc and 3 others6.6 million5.3%30 June 2026passive, institutional (13d-1(b))EDGAR
7 August 202613GState Street Corporation and 1 other5.8 million4.7%30 June 2026passive, institutional (13d-1(b))EDGAR
12 May 202613GState Street Corporation and 1 other6.3 million5.1%31 March 2026passive, institutional (13d-1(b))EDGAR
8 May 202613G/APrudential Financial Inc and 1 other5.3 million4.3%31 March 2026passive, institutional (13d-1(b))EDGAR
6 May 202613G/AJennison Associates LLC and 1 other5.0 million4.0%31 March 2026passive, institutional (13d-1(b))EDGAR
26 March 202613G/AThe Vanguard Group and 1 other00.0%13 March 2026passive, institutional (13d-1(b))EDGAR
13 February 202613G/APrudential Financial Inc and 1 other7.1 million5.7%31 December 2025passive, institutional (13d-1(b))EDGAR
13 February 202613G/ARubric Capital Management LP and 3 others8.3 million6.8%31 December 2025passive, institutional (13d-1(b))EDGAR
30 January 202613G/AJennison Associates LLC and 1 other6.8 million5.5%31 December 2025passive, institutional (13d-1(b))EDGAR
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder.
Read moreAmendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short. 13D and 13G

Fails to deliver

Settlement dateShares failedPriceFile
25 September 20262$26.27SEC
22 September 2026341$25.96SEC
21 September 202699$25.38SEC
3 September 2026803$23.85SEC
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period.
Read moreLargest in the window: 803 on 3 September 2026. A fail is an operational fact about settlement, not a position.